Whetstone discloses 5.3% Health Catalyst (HCAT) stake in 13G filing
Rhea-AI Filing Summary
Health Catalyst, Inc. received an updated ownership report showing that Whetstone Capital Advisors, LLC and David Atterbury together beneficially own 3,750,377 shares of its common stock. This stake represents 5.3% of the company’s outstanding common shares as of the reporting date.
The filing states that the reporting persons share both voting and dispositive power over all of these shares and have no sole voting or dispositive authority. They also certify that the shares were not acquired for the purpose of changing or influencing control of Health Catalyst.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership stake in HCAT does Whetstone Capital report?
Whetstone Capital Advisors, LLC and David Atterbury report beneficial ownership of 3,750,377 Health Catalyst common shares, representing 5.3% of the class.
Who are the reporting persons in this Health Catalyst (HCAT) Schedule 13G/A?
The reporting persons are Whetstone Capital Advisors, LLC and David Atterbury, who filed jointly as the beneficial owners of the shares.
What class of Health Catalyst (HCAT) securities is covered in this filing?
The filing covers common stock of Health Catalyst, Inc., with a par value of $0.001 per share and CUSIP 42225T107.
Is Whetstone’s HCAT position reported as passive or control-seeking?
The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of Health Catalyst.
What is the relevant date for this HCAT Schedule 13G/A ownership report?
The date of the event requiring the filing is listed as 12/31/2025.